MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.76 -0.13 (-7.39%)	---	-0.01 (-0.61%)	-0.13 (-7.39%)	---	---	-0.13 (-7.39%)	-0.13 (-7.39%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.09
Diluted EPS:: -0.09
Basic P/E:: -18.1111
Diluted P/E:: -18.1111
RSI(14) 1m:: 53.31
VWAP:: 1.64
RVol:: 0.0943

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	2.08 -0.07 (-3.15%)	Oct 16 11:26
1m	Price increase 1m	2.18 +0.03 (+1.31%)	Oct 16 11:23
1m	Price increase 1m	2.16 +0.03 (+1.41%)	Oct 16 11:21
1m	Price increase 1m	2.15 +0.02 (+1.18%)	Oct 16 11:16
1m	Price decrease 1m	2.12 -0.04 (-1.81%)	Oct 16 11:15